ArticlebioRxiv : the preprint server for biology2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection.
Carolin M Lieber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.